Glenmark Pharmaceuticals has informed that it has attached media release on 19th October 2020 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg’ which is self explanatory.
The above information is a part of company’s filings submitted to BSE.